A microneedle array module is disclosed comprising a multiplicity of microneedles affixed to and protruding outwardly from a front surface of a substrate to form the array, each microneedle of the array having a hollow section which extends through its center to an opening in the tip thereof. A method of fabricating the microneedle array module is also disclosed comprising the steps of: providing etch resistant mask layers to one and another opposite surfaces of a substrate to predetermined thicknesses; patterning the etch resistant mask layer of the one surface for outer dimensions of the microneedles of the array; patterning the etch resistant mask layer of the other surface for inner dimensions of the microneedles of the array; etching unmasked portions of the substrate from one and the other surfaces to first and second predetermined depths, respectively; and removing the mask layers from the one and the other surfaces. One embodiment of the method includes the steps of: providing an etch resistant mask layer to the other surface of the substrate to a predetermined thickness; patterning the etch resistant mask layer of the other surface to define a reservoir region in the substrate; and etching away the unmasked reservoir region of the substrate to form a reservoir well in the other surface of the substrate. A layer of material may be provided to the other surface to enclose the reservoir well and a passageway is provided through the layer to the well region.
|
1. A method of fabricating a microneedle array module comprising the steps of:
providing etch resistant mask layers to a first surface of a substrate to predetermined thicknesses;
patterning the etch resistant mask layer of the first surface for outer dimensions of the microneedles of said array;
etching unmasked portions of said substrate from the first surface to a first predetermined depth;
anisotropically etching underneath masked portions of the substrate from a second surface of the substrate to a second predetermined depth; and
removing the mask layers from the the first surface.
2. The method of
3. The method of
4. The method of
5. The method of
6. The method of
8. The method of
9. The method of
10. The method of
11. The method of
12. The method of
13. The method of
14. The method of
15. The method of
16. The method of
17. The method of
providing an etch resistant mask layer to the other surface of the substrate to a predetermined thickness;
patterning the etch resistant mask layer of the other surface to define a reservoir region in the substrate; and
etching away the unmasked reservoir region of the substrate to form a reservoir well in the other surface of the substrate.
18. The method of
providing a layer of material to the other surface to enclose the reservoir well; and
providing a passageway through said layer to the well region.
19. The method of
20. The method of
|
This application is a continuation of U.S. patent application Ser. No. 10/162,848, filed on Jun. 5, 2002, now U.S. Pat. No. 6,790,372, which is a Divisional of U.S. patent application Ser. No. 09/643,103 filed Aug. 21, 2000 (now abandoned).
The present invention is related to microelectromechanical systems (MEMS) and the fabrication thereof, in general, and more specifically, to a microneedle array module and its fabrication.
Targeted drug delivery or the application of a high concentration of one or more drugs to a specific target area within the body has become of paramount importance to the fight against tumors, restentosis and similar life threatening medical conditions. Generally, these target areas are reachable through the walls of the blood vessels of the body. Present systems use a catheter with an imaging device to locate the target area. Once located, a specific drug or drugs are delivered to the targeted vessel wall area. But, this process has posed serious problems.
One approach provides a drug inside a perforated balloon at the end of the catheter. When the balloon reaches the target area, it is inflated causing the drug to be released through the perforations of the balloon locally around the targeted walls of the vessel. This perfusion of the drug at the surface of the vessel walls relies heavily on the drug being absorbed quickly and efficiently by the vessel walls at the target area. However, in some cases the drug may not be absorbed by the vessel walls very effectively. In these cases, the drug may be caused to move downstream with the blood stream which may cause adverse medical effects to portions of the body not intended to receive the drugs, especially at such high concentrations. The drugs may also be diluted in this delivery process and lose their effectiveness. In any event, these relatively expensive drugs may not be achieving their intended purpose.
Some recent drug delivery systems, like those proposed in the U.S. Pat. Nos. 5,112,305; 5,242,397; 5,681,281; 5,713,863 and 5,746,716, for example, provide for a studded balloon catheter. The balloon or portions thereof contain the drug or drugs to be delivered to the target area. When the balloon reaches the target area, it is inflated causing the studs to press against the vessel walls. The drug is then forced from the balloon through the studs into the surface of the vessel walls. However, the stud protrusions of the balloon are not needles and thus, are not very efficient at puncturing the vessel walls, especially at depths adequate for injecting the specific drug.
What is needed for effective drug delivery is an array of microneedles of sufficient length which may be deployed to the target site within the body and adequately penetrate the vessel walls thereat to permit the drug to effectively act on the target area at the high concentrations intended. Such an array structure may also be used transdermally for drug delivery as well.
In accordance with one aspect of the present invention, a microneedle array module comprises a multiplicity of microneedles affixed to and protruding outwardly from a front surface of a substrate to form the array, each microneedle of the array having a hollow section which extends through its center to an opening in the tip thereof. The substrate includes an array of holes which align with the hollow sections of the microneedles and extend through the substrate to a back surface thereof, whereby a liquid applied to the back surface of the substrate may be forced through the holes in the substrate and out through the tips of the microneedle array thereof. In one embodiment, the substrate includes a reservoir well in the back surface thereof. The well extends over the array of holes in the back surface and may be covered by a layer of material which is affixed to the back surface peripheral the well, the layer including an interconnecting passageway to the well.
In accordance with another aspect of the present invention, a method of fabricating a microneedle array module comprises the steps of: providing etch resistant mask layers to one and another opposite surfaces of a substrate to predetermined thicknesses; patterning the etch resistant mask layer of the one surface for outer dimensions of the microneedles of the array; patterning the etch resistant mask layer of the other surface for inner dimensions of the microneedles of the array; etching unmasked portions of the substrate from one and the other surfaces to first and second predetermined depths, respectively; and removing the mask layers from the one and the other surfaces. One embodiment of the method includes the steps of: providing an etch resistant mask layer to the other surface of the substrate to a predetermined thickness; patterning the etch resistant mask layer of the other surface to define a reservoir region in the substrate; and etching away the unmasked reservoir region of the substrate to form a reservoir well in the other surface of the substrate. A layer of material may be provided to the other surface to enclose the reservoir well and a passageway is provided through said layer to the well region.
In
Also, in the step of
Another etch resistant mask layer 16 is provided over the back surface 14 including the well region 22 to an approximate thickness of 1.5 μm, for example, using a thermal oxidation process or other process in a similar manner as described above and is patterned using a conventional thick photoresist photolithography and a BHF etch or fluorocarbon-based RIE process to define the inner dimensions or openings of the microneedles of the array, which may be on the order of 15-20 μm, for example, as shown in
In the step of
The resulting fabricated microneedles of the array protruding from the remaining layer 30 of the substrate 10 are cylindrical in shape and substantially the same in dimension, having approximately 300 μm in height, for example. However, it is understood that the foregoing described fabrication process may produce microneedles having height dimensions that are greater than the dimension of the remaining thickness 30 of the substrate material. In addition, the fabrication process described above may be applied to starting substrates of different thicknesses to produce protruding dimensions of the microneedles that may range from 50-2000 μm, for example. Accordingly, the resulting microneedle array module comprises: a substrate having front and back surfaces; and a multiplicity of microneedles that protrude outwardly from the front surface to form the array, each microneedle including a hollow section which extends through its center to an opening in the tip thereof. The substrate includes an array of holes which align with the hollow sections of the microneedles and extend to the back surface as shown in
While the fabrication method described in connection with
In
Two three-dimensional views of one embodiment of a microneedle array module is shown in
While the present invention has been described herein above in connection with one or more embodiments, it is understood that these embodiments are used merely by way of example. Accordingly, the present invention should not be limited to any such embodiments, but rather construed in breadth and broad scope in accordance with the appended claims.
Roy, Shuvo, Fleischman, Aaron J.
Patent | Priority | Assignee | Title |
10092207, | May 15 2016 | Biolinq, Inc. | Tissue-penetrating electrochemical sensor featuring a co-electrodeposited thin film comprised of polymer and bio-recognition element |
10384005, | Dec 17 2007 | New World Pharmaceuticals, LLC | Integrated intra-dermal delivery, diagnostic and communication system |
10786669, | Oct 02 2006 | EMKINETICS, INC | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
11045142, | Apr 29 2017 | Biolinq, Inc. | Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry |
11224742, | Oct 02 2006 | EMKinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
11247053, | Oct 02 2006 | EMKinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
11406818, | May 15 2016 | Biolinq Incorporated | Tissue-penetrating electrochemical sensor featuring a co-electrodeposited thin film comprised of polymer and bio-recognition element |
11478194, | Jul 29 2020 | Biolinq Incorporated | Continuous analyte monitoring system with microneedle array |
11628300, | Oct 02 2006 | EMKinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
11844943, | Oct 02 2006 | EMKinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
11857344, | May 08 2021 | Biolinq Incorporated | Fault detection for microneedle array based continuous analyte monitoring device |
11872055, | Jul 29 2020 | Biolinq Incorporated | Continuous analyte monitoring system with microneedle array |
7491341, | Mar 31 2006 | Battelle Memorial Institute | Method of making tapered capillary tips with constant inner diameters |
7648484, | Aug 28 2000 | NANOPASS TECHNOLOGIES LTD | Microneedle structure and production method therefor |
8007466, | Feb 11 2005 | NANOPASS TECHNOLOGIES LTD | System and method for delivering fluid into flexible biological barrier |
8294757, | Jun 26 2007 | Agency for Science, Technology and Research | Imaging chamber with window and micro-needle platform magnetically biased toward each other |
8430805, | Oct 02 2006 | EMKINETICS, INC | Method and apparatus for magnetic induction therapy |
8435166, | Oct 02 2006 | EMKINETICS, INC | Method and apparatus for magnetic induction therapy |
8588884, | May 28 2010 | EMKINETICS, INC | Microneedle electrode |
9002477, | Oct 02 2006 | EMKinetics, Inc.; EMKINETICS, INC | Methods and devices for performing electrical stimulation to treat various conditions |
9005102, | Oct 02 2006 | EMKINETICS, INC | Method and apparatus for electrical stimulation therapy |
9022973, | Dec 17 2007 | New World Pharmaceuticals, LLC | Integrated intra-dermal delivery, diagnostic and communication system |
9339641, | Oct 02 2006 | EMKINETICS, INC | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
9387338, | Oct 02 2006 | EMKinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
9610459, | Jul 24 2009 | EMKINETICS, INC | Cooling systems and methods for conductive coils |
9630004, | Oct 02 2006 | EMKinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
9757584, | Oct 02 2006 | EMKinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
9933387, | Sep 07 2014 | Biolinq, Inc. | Miniaturized sub-nanoampere sensitivity low-noise potentiostat system |
D875254, | Jun 08 2018 | Biolinq, Inc.; BIOLINQ, INC | Intradermal biosensor |
D988160, | Mar 16 2021 | Biolinq Incorporated | Wearable dermal sensor |
ER1067, | |||
ER5271, | |||
ER6729, | |||
ER7357, |
Patent | Priority | Assignee | Title |
5112305, | Jun 20 1989 | CEDARS-SINAI MEDICAL CENTER, A CORP OF CA | Catheter device for intramural delivery of therapeutic agents |
5242397, | Jan 31 1990 | Cedars-Sinai Medical Center | Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to prevent restenosis after balloon angioplasty |
5279544, | Mar 13 1992 | Elan Pharma International Limited | Transdermal or interdermal drug delivery devices |
5354279, | Oct 21 1992 | Bavaria Medizin Technologie GmbH | Plural needle injection catheter |
5364356, | Jul 19 1993 | Bavaria Medizin Technologie GmbH | Sleeve catheter |
5457041, | Mar 25 1994 | Leidos, Inc | Needle array and method of introducing biological substances into living cells using the needle array |
5547467, | Jan 21 1988 | Massachusetts Institute of Technology | Method for rapid temporal control of molecular transport across tissue |
5667491, | Jan 21 1988 | Massachusetts Institute of Technology | Method for rapid temporal control of molecular transport across tissue |
5681281, | Jul 10 1995 | SciMed Life Systems, INC | Catheter with fluid medication injectors |
5713863, | Jan 11 1996 | SciMed Life Systems, INC | Catheter with fluid medication injectors |
5746716, | Jul 10 1995 | INTERVENTIONAL TECHNOLOGIES INC | Catheter for injecting fluid medication into an arterial wall |
5879326, | May 22 1995 | Massachusetts General Hospital | Method and apparatus for disruption of the epidermis |
5911223, | Aug 11 1995 | Massachusetts Institute of Technology; Regents of the University of California, The | Introduction of modifying agents into skin by electroporation |
6051503, | Aug 01 1996 | Robert Bosch GmbH | Method of surface treatment of semiconductor substrates |
6087197, | Nov 02 1993 | Matsushita Electric Industrial Co., Ltd. | Aggregate of semiconductor micro-needles and method of manufacturing the same, and semiconductor apparatus and method of manufacturing the same |
6102904, | Jul 10 1995 | SciMed Life Systems, INC | Device for injecting fluid into a wall of a blood vessel |
6256533, | Jun 09 1999 | CORIUM, INC | Apparatus and method for using an intracutaneous microneedle array |
6312612, | Jun 09 1999 | CORIUM, INC | Apparatus and method for manufacturing an intracutaneous microneedle array |
6331266, | Sep 29 1999 | Becton, Dickinson and Company | Process of making a molded device |
6334856, | Jun 10 1998 | VALERITAS LLC | Microneedle devices and methods of manufacture and use thereof |
6379324, | Jun 09 1999 | CORIUM, INC | Intracutaneous microneedle array apparatus |
6790372, | Aug 21 2000 | Cleveland Clinic Foundation | Microneedle array module and method of fabricating the same |
6821281, | Oct 16 2000 | CORIUM, INC | Microstructures for treating and conditioning skin |
20020020688, | |||
20020082543, | |||
20030135167, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 06 2004 | The Cleveland Clinic Foundation | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Mar 08 2011 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
Mar 08 2011 | M2554: Surcharge for late Payment, Small Entity. |
Mar 10 2015 | M2552: Payment of Maintenance Fee, 8th Yr, Small Entity. |
Mar 10 2015 | M2555: 7.5 yr surcharge - late pmt w/in 6 mo, Small Entity. |
Feb 28 2019 | M2553: Payment of Maintenance Fee, 12th Yr, Small Entity. |
Date | Maintenance Schedule |
Aug 28 2010 | 4 years fee payment window open |
Feb 28 2011 | 6 months grace period start (w surcharge) |
Aug 28 2011 | patent expiry (for year 4) |
Aug 28 2013 | 2 years to revive unintentionally abandoned end. (for year 4) |
Aug 28 2014 | 8 years fee payment window open |
Feb 28 2015 | 6 months grace period start (w surcharge) |
Aug 28 2015 | patent expiry (for year 8) |
Aug 28 2017 | 2 years to revive unintentionally abandoned end. (for year 8) |
Aug 28 2018 | 12 years fee payment window open |
Feb 28 2019 | 6 months grace period start (w surcharge) |
Aug 28 2019 | patent expiry (for year 12) |
Aug 28 2021 | 2 years to revive unintentionally abandoned end. (for year 12) |